Vir goes Grinch, eliminating 75 posts and shuttering 2 US sites to slow erosion of $1.7B cash pile

Vir Biotechnology has delivered unseasonably gloomy news to its employees, outlining plans to eliminate 75 positions and shutter two U.S. facilities to save more than $40 million a year.